# Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.

**Autores:** Woodfin AA, Yam C, Teshome M et al.
**Revista:** Ann Surg Oncol (2023)
**PMID:** 37973647 | **PMCID:** —
**DOI:** [10.1245/s10434-023-14541-w](https://doi.org/10.1245/s10434-023-14541-w)
**Fuente:** PubMed (abstract only — full text vía DOI)

## Relevancia
Datos sobre respuesta nodal patológica completa y manejo axilar en cáncer de mama triple negativo tras quimio-/inmunoterapia neoadyuvante; informa la decisión de SLNB/TAD vs. ALND.

## Abstract
Triple-negative breast cancer (TNBC) is known to portend a worse prognosis compared with same-stage, hormone receptor-positive disease. However, with the recent change in practice to include pembrolizumab in neoadjuvant chemotherapy (NAC) for TNBC, an increase in pathologic complete responses (pCRs) has been reported. The perioperative repercussions of adding pembrolizumab to standard NAC regimens for TNBC are currently unknown. We aimed to explore the perioperative implications of adding pembrolizumab to standard NAC regimens for non-metastatic TNBC.

This was a retrospective review of the perioperative outcomes in patients with non-metastatic TNBC treated with pembrolizumab-NAC from January 2018 to October 2022 conducted at a high-volume cancer center. Patient demographics, comorbidities, clinical and pathological staging, NAC treatment regimen, initiation, and completion, as well as date of surgery and postoperative complications were analyzed.

Of 87 patients, 67.8% had an overall pCR and 86% had an axillary pCR; 37.2% of cN+ patients were spared from axillary lymph node dissection. However, 24.1% of patients experienced surgical complications, 9% of patients were receiving steroids at the time of breast surgery secondary to adverse effects of pembrolizumab-NAC, and 7% underwent a change in the initial surgical plan such as omission of reconstruction.

Pembrolizumab-NAC has not only significant oncologic benefit but also noteworthy perioperative implications in the surgical management of TNBC.

## Acceso
Vía [DOI](https://doi.org/10.1245/s10434-023-14541-w) o suscripción institucional.

---
*Datos de PubMed. Citar: doi 10.1245/s10434-023-14541-w*
